Persistent disease burden despite advanced therapies in inflammatory bowel disease: a real-world patient-reported survey from Greece - Poll - MDSpire

Persistent disease burden despite advanced therapies in inflammatory bowel disease: a real-world patient-reported survey from Greece

  • By

  • Charalampos Tzanetakos

  • Vasiliki-Rafaela Vakouftsi

  • George Mavridoglou

  • Andriani Angelopoulou

  • George Gourzoulidis

  • July 10, 2026

  • 0 min

Share

Original Source(s)

Persistent disease burden despite advanced therapies in inflammatory bowel disease: a real-world patient-reported survey from Greece

  • by Charalampos Tzanetakos, Vasiliki-Rafaela Vakouftsi, George Mavridoglou, Andriani Angelopoulou, George Gourzoulidis

  • July 10, 2026

Related Content

Editorial: Biomarkers and beyond: predicting course and tailoring treatment in inflammatory bowel diseases

Casein hydrolysate promotes intestinal repair in adult mice with Salmonella enteritis through a lactate-GPR81-Wnt3A axis in intestinal stem cell niche

Cardiovascular risk in inflammatory bowel disease: focus on lipids and visceral adipose tissue